The difference is not dramatic for GI symptoms specifically
Wegovy has been approved for adults with moderate to advanced liver fibrosis (stages F2 to F3), alongside a reduced-calorie diet and increased physical activity
A self-regulation program for maintenance of weight loss
At the same time as the UCL study was released, another study of a new drug, retatrutide, found that it could be even more effective with participants losing 24% of their body weight over 48 weeks, partly because it has an impact on metabolism as well as appetite
I joined MDWatch in March 2025 at 246 lbs
For example, Medicare and Medicaid may cover Mounjaro for type 2 diabetes, and in some cases, Zepbound for sleep apnea, but theyre less likely to cover Zepbound for weight loss